基本资料 投资组合 财务数据 基金公告
创金合信全球医药生物股票发起(QDII)A(018155) |
净值：
1.6295
|
日增长率：
-0.53%
|
累计净值：1.6295 | 2026-05-12 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| EWTX | Edgewise Therapeutics Inc | 62,071.00 | 13,529,063.44 | 4.59 |
| SMMT | Summit Therapeutics Inc | 101,501.00 | 13,316,101.33 | 4.52 |
| ANAB | AnaptysBio Inc | 30,451.00 | 11,685,568.94 | 3.97 |
| CELC | Celcuity LLC | 12,886.00 | 10,177,109.15 | 3.46 |
| PTGX | Protagonist Therapeutics Inc | 13,206.00 | 9,631,198.66 | 3.27 |
| NKTR | 内克塔治疗 | 18,784.00 | 9,351,629.99 | 3.17 |
| BNTX | BioNTech SE ADR | 15,194.00 | 9,344,253.36 | 3.17 |
| NAMS | NewAmsterdam Pharma Co NV | 41,708.00 | 9,237,904.67 | 3.14 |
| COGT | Cogent Biosciences Inc | 31,577.00 | 8,409,829.97 | 2.86 |
| ABVX | Abivax SA ADR | 9,720.00 | 7,489,018.85 | 2.54 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-03-31 | 79.10 | - | 20.45 | 294,545,476.27 |
| 2025-12-31 | 89.93 | - | 20.40 | 825,065,395.56 |
| 2025-09-30 | 85.79 | - | 13.08 | 39,332,950.53 |
| 2025-06-30 | 84.55 | - | 9.62 | 13,846,914.86 |
| 2025-03-31 | 84.53 | - | 18.85 | 12,369,113.13 |
微信公众号
证券之星APP
